AmREIT, Inc. Proposed Acquisition by Regency Centers Corporation May Not be in the Best Interests of AMRE Shareholders

New York, New York, UNITED STATES

NEW YORK, July 15, 2014 (GLOBE NEWSWIRE) -- The proposed acquisition of AmREIT, Inc. ("AMRE" or the "Company") by Regency Centers Corporation ("REG") is the subject of an examination by WeissLaw LLP, a national class action, shareholder rights law firm.

On July 10, 2014, AMRE announced that it had received an unsolicited proposal for REG to acquire all of the Company's outstanding common stock for $22.00 per share in cash and/or stock of REG. Notably, prior to the announcement of the REG proposal, at least one analyst set a price target for AMRE stock at $25.00 – or $3.00 above the price offered by REG.

Given these facts, WeissLaw's investigation concerns the fairness of the REG proposal, and adequacy of the procedures adopted by AMRE to respond to the proposal. If you own AMRE shares and would like more information about your rights or our investigation, please contact Joshua Rubin or Kelly Keenan either by telephone at (888) 593-4771 or by email at

The firm is also in the process of investigations on behalf of shareholders of URS Corporation, Medical Action Industries Inc., PLX Technologies, Integrys Energy Group, and Measurement Specialties, Inc.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at or fill out the form on our website,

Attorney Advertising. Past results do not guarantee a similar outcome.


Contact Data